Andres Y. Maldonado
Stock Analyst at HC Wainwright & Co.
(4.56)
# 263
Out of 5,005 analysts
15
Total ratings
71.43%
Success rate
20.46%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MRUS Merus | Downgrades: Neutral | $135 → $97 | $94.29 | +2.87% | 1 | Sep 30, 2025 | |
CADL Candel Therapeutics | Reiterates: Buy | $23 | $5.56 | +313.67% | 1 | Sep 29, 2025 | |
MNPR Monopar Therapeutics | Maintains: Buy | $70 → $105 | $99.39 | +5.64% | 2 | Sep 29, 2025 | |
SRRK Scholar Rock Holding | Maintains: Buy | $50 → $44 | $37.47 | +17.43% | 1 | Sep 23, 2025 | |
CRBP Corbus Pharmaceuticals Holdings | Reiterates: Buy | $40 | $14.83 | +169.72% | 1 | Sep 17, 2025 | |
CGON CG Oncology | Reiterates: Buy | $75 | $39.82 | +88.35% | 3 | Sep 15, 2025 | |
ENGN enGene Holdings | Reiterates: Buy | $25 | $7.75 | +222.58% | 2 | Sep 12, 2025 | |
IBRX ImmunityBio | Reiterates: Buy | $8 | $2.54 | +214.96% | 1 | Sep 10, 2025 | |
IMAB I-Mab | Reiterates: Buy | $7 | $4.32 | +62.04% | 1 | Aug 21, 2025 | |
AURA Aura Biosciences | Reiterates: Buy | $22 | $6.05 | +263.64% | 1 | Aug 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $15.94 | +25.47% | 1 | Aug 8, 2025 |
Merus
Sep 30, 2025
Downgrades: Neutral
Price Target: $135 → $97
Current: $94.29
Upside: +2.87%
Candel Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $23
Current: $5.56
Upside: +313.67%
Monopar Therapeutics
Sep 29, 2025
Maintains: Buy
Price Target: $70 → $105
Current: $99.39
Upside: +5.64%
Scholar Rock Holding
Sep 23, 2025
Maintains: Buy
Price Target: $50 → $44
Current: $37.47
Upside: +17.43%
Corbus Pharmaceuticals Holdings
Sep 17, 2025
Reiterates: Buy
Price Target: $40
Current: $14.83
Upside: +169.72%
CG Oncology
Sep 15, 2025
Reiterates: Buy
Price Target: $75
Current: $39.82
Upside: +88.35%
enGene Holdings
Sep 12, 2025
Reiterates: Buy
Price Target: $25
Current: $7.75
Upside: +222.58%
ImmunityBio
Sep 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.54
Upside: +214.96%
I-Mab
Aug 21, 2025
Reiterates: Buy
Price Target: $7
Current: $4.32
Upside: +62.04%
Aura Biosciences
Aug 13, 2025
Reiterates: Buy
Price Target: $22
Current: $6.05
Upside: +263.64%
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $20
Current: $15.94
Upside: +25.47%